MoonLake Immunotherapeutics
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phas…
Biotechnology
CH, Zug [HQ]
Lobbying · US Senate · Influence
Lobbying Analysis
Lobbying · US Senate · Influence
MoonLake Immunotherapeutics has no lobbying expenses in our database.
| FY | Quarter | Lobby Expense [in mil. $] | Filing | Report Time |
|---|---|---|---|---|
| No data |